Telehealth of cardiac devices for CVD treatment-Reference-Cited by-同舟云学术

Telehealth of cardiac devices for CVD treatment

Published:2023-12-27 Issue: Volume: Page:
ISSN:0006-3592
Container-title:Biotechnology and Bioengineering
language:en
Short-container-title:Biotech & Bioengineering

Author:

Shelke Sushil¹,Veerubhotla Krishna¹,Lee Yugyung²,Lee Chi H.¹^ORCID

Affiliation:

1. Division of Pharmacology and Pharmaceutics Sciences, School of Pharmacy University of Missouri‐Kansas City Kansas City Missouri USA

2. Division of Computer Science, School of Science and Engineering University of Missouri‐Kansas City Kansas City Missouri USA

Abstract

AbstractThis review covers currently available cardiac implantable electronic devices (CIEDs) as well as updated progress in real‐time monitoring techniques for CIEDs. A variety of implantable and wearable devices that can diagnose and monitor patients with cardiovascular diseases are summarized, and various working mechanisms and principles of monitoring techniques for Telehealth and mHealth are discussed. In addition, future research directions are presented based on the rapidly evolving research landscape including Artificial Intelligence (AI).

Publisher

Wiley

Subject

Applied Microbiology and Biotechnology,Bioengineering,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/bit.28637

Reference109 articles.

1. Abbott. (2022 February 7). Abbott announces world's first implant of dual‐chamber leadless pacemaker in pivotal trial.https://Abbott.Mediaroom.Com/2022-02-07-Abbott-Announces-Worlds-First-Implant-of-Dual-Chamber-Leadless-Pacemaker-in-Pivotal-Trial.

2. European Society of Cardiology quality indicators for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

3. Label-Free Electrochemical Sensor Based on Manganese Doped Titanium Dioxide Nanoparticles for Myoglobin Detection: Biomarker for Acute Myocardial Infarction

4. A brief history of cardiac pacing;Aquilina O.;Images in Paediatric Cardiology,2006

5. Morphine use and myocardial reperfusion in patients with acute myocardial infarction treated with primary PCI